These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 17240090)

  • 1. Bone mineral density in breast cancer patients with positive estrogen receptor tumor status.
    Douchi T; Yonehara Y; Kosha S; Iwamoto I; Rai Y; Sagara Y; Umekita Y
    Maturitas; 2007 Jul; 57(3):221-5. PubMed ID: 17240090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aromatase inhibitor-induced bone mineral loss and its prevention by bisphosphonate administration in postmenopausal breast cancer patients.
    Yonehara Y; Iwamoto I; Kosha S; Rai Y; Sagara Y; Douchi T
    J Obstet Gynaecol Res; 2007 Oct; 33(5):696-9. PubMed ID: 17845332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation of estrogen receptor expression in endometrial cancer specimens to bone mineral density.
    Douchi T; Tsuji T; Tokuhisa T; Fujie Y; Katanozaka M; Yoshinaga M; Nagata Y
    Acta Obstet Gynecol Scand; 2000 Nov; 79(11):1011-4. PubMed ID: 11081689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between bone mass, invasive breast cancer incidence and raloxifene therapy in postmenopausal women with low bone mass or osteoporosis.
    Burshell AL; Song J; Dowsett SA; Mershon JL; Delmas PD; Secrest RJ; Cauley JA
    Curr Med Res Opin; 2008 Mar; 24(3):807-13. PubMed ID: 18254988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between estrogen receptor concentration in breast cancer tissue and bone mineral density.
    Sriussadaporn S; Srimuninnimit V; Ploybutr S; Tanlakit M; Chearskul S; Chakrapee-Sirisuk S; Nitiyanant W; Vannasaeng S; Sinlarat P; Vichayanrat A
    J Med Assoc Thai; 2002 Mar; 85(3):327-33. PubMed ID: 12117021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone mineral density and risk of postmenopausal breast cancer.
    Grenier D; Cooke AL; Lix L; Metge C; Lu H; Leslie WD
    Breast Cancer Res Treat; 2011 Apr; 126(3):679-86. PubMed ID: 20838879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteoporosis and rate of bone loss among postmenopausal survivors of breast cancer.
    Chen Z; Maricic M; Pettinger M; Ritenbaugh C; Lopez AM; Barad DH; Gass M; Leboff MS; Bassford TL
    Cancer; 2005 Oct; 104(7):1520-30. PubMed ID: 16110508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationships among serum receptor of nuclear factor-kappaB ligand, osteoprotegerin, high-sensitivity C-reactive protein, and bone mineral density in postmenopausal women: osteoimmunity versus osteoinflammatory.
    Nabipour I; Larijani B; Vahdat K; Assadi M; Jafari SM; Ahmadi E; Movahed A; Moradhaseli F; Sanjdideh Z; Obeidi N; Amiri Z
    Menopause; 2009; 16(5):950-5. PubMed ID: 19387415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone mineral density and bone turnover in postmenopausal women treated for breast cancer.
    Waltman NL; Ott CD; Twiss JJ; Gross GJ; Lindsey AM; Moore TE
    Cancer Nurs; 2008; 31(3):182-90. PubMed ID: 18453874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
    Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A
    Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bone mineral density in premenopausal and postmenopausal women between 50-55 and 50-57 years of age].
    Enchev E; Botushanov N; Dzhambazova E
    Akush Ginekol (Sofiia); 2007; 46(2):14-7. PubMed ID: 17469445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting risk of breast cancer in postmenopausal women by hormone receptor status.
    Chlebowski RT; Anderson GL; Lane DS; Aragaki AK; Rohan T; Yasmeen S; Sarto G; Rosenberg CA; Hubbell FA;
    J Natl Cancer Inst; 2007 Nov; 99(22):1695-705. PubMed ID: 18000216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between breast density and bone mineral density in postmenopausal women.
    Buist DS; Anderson ML; Taplin SH; LaCroix AZ
    Cancer; 2004 Nov; 101(9):1968-76. PubMed ID: 15386302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of long-term treatment with raloxifene on mammary density in postmenopausal women.
    Lasco A; Gaudio A; Morini E; Morabito N; Nicita-Mauro C; Catalano A; Denuzzo G; Sansotta C; Xourafa A; Macrì I; Frisina N
    Menopause; 2006; 13(5):787-92. PubMed ID: 16912660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen-dependent increase in bone turnover and bone loss in postmenopausal women with breast cancer treated with anastrozole. Prevention with bisphosphonates.
    Confavreux CB; Fontana A; Guastalla JP; Munoz F; Brun J; Delmas PD
    Bone; 2007 Sep; 41(3):346-52. PubMed ID: 17618847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lumbar spine bone mineral density changes in patients with primary hyperparathyroidism according to age and gender.
    Lumachi F; Camozzi V; Ermani M; Nardi A; Luisetto G
    Ann N Y Acad Sci; 2007 Nov; 1117():362-6. PubMed ID: 17656570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone mineral density in breast cancer patients with estrogen receptor-negative tumor.
    Dede DS; Dizdar O; Harputluoglu H; Altundag K
    Maturitas; 2007 Nov; 58(3):324. PubMed ID: 17945443
    [No Abstract]   [Full Text] [Related]  

  • 18. Association between polymorphisms in tumor necrosis factor (TNF) and TNF receptor genes and circulating TNF, soluble TNF receptor levels, and bone mineral density in postmenopausal Korean women.
    Kim H; Chun S; Ku SY; Suh CS; Choi YM; Kim JG
    Menopause; 2009; 16(5):1014-20. PubMed ID: 19369902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between body mass index, waist circumference and waist to hip ratio and the steroid hormone receptor status in breast carcinoma of pre- and postmenopausal women.
    Pinheiro RL; Sarian LO; Pinto-Neto AM; Morais S; Costa-Paiva L
    Breast; 2009 Feb; 18(1):8-12. PubMed ID: 19041243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen receptor expression in benign breast ductal cells obtained from random periareolar fine needle aspiration correlates with menopausal status and cytomorphology index score.
    Sharma P; Kimler BF; Warner C; Metheny T; Xue Q; Zalles CM; Fabian CJ
    Breast Cancer Res Treat; 2006 Nov; 100(1):71-6. PubMed ID: 16791479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.